Please login to the form below

Not currently logged in
Email:
Password:

Suzanne Gagnon joins Idis as CMO

She was formerly chief medical officer at Icon

Idis Suzanne GagnonIdis has appointed Dr Suzanne Gagnon as its first chief medical officer.

Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access to medicines.

She was most recently chief medical officer at neuroscience company NuPathe, prior to which she spent ten years as chief medical officer at the clinical research organisation (CRO) Icon,

During her time at Icon, she gained senior level experience in medical, regulatory and clinical research operations, overseeing a staff of 400 professionals across 10 global locations.

"Suzanne brings senior leadership to our team and a unique blend of industry expertise to our customers that will help guide development and implementation of programmes that balance stakeholder requirements and effectively address the needs of patients," said Natalie Douglas, CEO of Idis. 

In addition to her industry experience, Dr Gagnon is adjunct professor, pharmaceutical product development at West Chester University, Pennsylvania.

13th March 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
foxandcat.online

some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...